| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 29 |
| 1 | METHOTREXATE SODIUM | 25 |
| 2 | METHOTREXATE | 22 |
| 3 | ETANERCEPT | 15 |
| 4 | TOCILIZUMAB | 12 |
| 5 | HYDROXYCHLOROQUINE SULFATE | 11 |
| 6 | ADALIMUMAB-AATY | 10 |
| 7 | ADALIMUMAB-ADAZ | 10 |
| 8 | ADALIMUMAB-FKJP | 10 |
| 9 | GOLIMUMAB | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHENODIOL | 1 | 0.0028 |
| 1 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 2 | GOLIMUMAB | 8 | 0.0006 |
| 3 | TURMERIC | 2 | 0.0004 |
| 4 | VINORELBINE | 2 | 0.0003 |
| 5 | ADALIMUMAB-FKJP | 10 | 0.0002 |
| 6 | TAFAMIDIS MEGLUMINE | 1 | 0.0002 |
| 7 | ERGOCALCIFEROL | 6 | 0.0002 |
| 8 | ADALIMUMAB-AATY | 10 | 0.0002 |
| 9 | TEMOZOLOMIDE | 4 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 3 | Interleukin-17A Antagonist [EPC] | 6 | 0.0002 |
| 4 | PCSK9 Inhibitor [EPC] | 3 | 0.0001 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 12 | 0.0001 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 22 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 12 | 0.0000 |
| 9 | Microtubule Inhibitor [EPC] | 8 | 0.0000 |